Navigation Links
Enzyme can steer cells or possibly stop them in their tracks
Date:3/18/2011

March 17, 2011 (BRONX, NY) Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that members of an enzyme family found in humans and throughout the plant and animal kingdoms play a crucial role in regulating cell motility. Their findings suggest an entirely new strategy for treating conditions ranging from diabetic ulcers to metastatic cancer.

David Sharp, Ph.D., associate professor of physiology & biophysics, was the senior author of the study, which was published in the March 6 online edition of Nature Cell Biology.

"Cells in our bodies are in constant motion, migrating from their birth sites to distant targets," said Dr. Sharp. "Cellular movement builds our tissues and organs and underlies key functions such as the immune response and wound healing. But uncontrolled cell migration can lead to devastating problems including mental retardation, vascular disease and metastatic cancer."

Dr. Sharp and his colleagues found that certain members of an enzyme family known as katanin concentrate at the outer edge of non-dividing cells where they break up microtubules dynamic intracellular polymers that regulate cell movement by controlling the formation of protrusions called lamellipodia. (Polymers are large molecules composed of many repeating units.)

When Dr. Sharp's team treated motile cells of the fruit fly Drosophila with a drug that inhibited katanin production, the treated cells moved significantly faster than control cells and with a striking increase in high-velocity movements, indicating that katanin prevents cells from moving too rapidly or in an uncontrolled manner. The researchers observed similar effects with katanin when they examined human cells.

"Our study opens up a new avenue for developing therapeutic agents for treating wounds burns and diabetic ulcers, for example as well as metastatic disease," added Dr. Sharp.

Describing katanin as a "microtubule regulator," Dr. Sharp said that its ability to modulate the speed and direction of cell movement and not just control whether or not it occurs could be especially useful from a clinical standpoint. Drugs that inhibit katanin, for example, could encourage cells to migrate in a particular direction to heal wounds. Conversely, he said, katanin itself or drugs that stimulate its production might be useful in treating or preventing cancer metastasis.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. Production of mustard oils: On the origin of an enzyme
2. Study analyzes role of PARP enzyme in eukaryotes
3. Enzymes from garden compost could favour bioethanol production
4. Enzyme enhances, erases long-term memories in rats
5. DSM and Codexis Sign Enzyme Supply Agreement
6. 1 group of enzymes could have a positive impact on health, from cholesterol to osteoporosis
7. Team looks to the cow rumen for better biofuels enzymes
8. 2 bacterial enzymes confer resistanceto common herbicide, say MU researchers
9. How the hat fits: Structural biology study reveals shape of epigenetic enzyme complex
10. Chemists document workings of key staph enzyme -- and how to block it
11. Enzyme Engineering XXI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/7/2017)... , March 7, 2017 Brandwatch , the ... by The Prince,s Trust to uncover insights to support ... The Trust. The UK,s leading youth charity will be ... campaign results and get a better understanding of the topics and ... ...
(Date:3/6/2017)... March 6, 2017 Mintigo , ... today announced Predictive Sales Coach TM , its ... sales intelligence into Salesforce. This unique AI application ... sales organizations with deep knowledge of their customers ... intelligent engagement. Predictive Sales Coach extends Mintigo,s existing ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... , March 22, 2017  Ascendis Pharma ... its innovative TransCon technology to address significant unmet ... results for the full year ended December 31, ... year for our company as we broadened our ... leading, integrated rare disease company with an initial ...
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
(Date:3/22/2017)... , March 22, 2017   iSpecimen ®, ... that Doctors Pathology Service (DPS), a full-service ... the United States , has joined ... Health Information Network (DHIN) to make human biospecimens ... The novel program, announced in 2015 as a ...
Breaking Biology Technology: